New drug for lupus nephritis has entered Phase III clinical trials
-
Last Update: 2020-07-08
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
, the 8th International Lupus Academic Conference opened in ShanghaiMore than 2,000 lupus doctors from around the world conductacademic exchanges on the latest advances in basic research and clinical prevention, diagnosis and treatment of lupus, and how to improve the quality of life of lupus patientsThe latest information on the treatment of a new generation of immunosuppressants for lupus nephritis has entered The Phase III clinical trial phaseLupus, a chronic autoimmunedisease, is more common inwomen, especially women of childbearing age, the ratio of men to women is about 1:9Systemic lupus is a chronic autoimmunedisease that affects the whole body
, the body's immune dysfunction, can affect any tissue and organ of the bodySystemic lupus is often stubborn and difficult to treat, and is a world-wide treatment problemIt is estimated that there are about one million patients with systemic lupus in China, and the trend is increasing year by year, more than half of which will induce lupus nephritis(reproduced from Beijing Youth Daily)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
